LINC01106: A Potential Drug Target for Cancer and Neurodegenerative Diseases

Target Name: LINC01106

NCBI ID: G151009

Other Name(s): FLJ38359 | DKFZp686K04236 | long intergenic non-protein coding RNA 1106 | Long intergenic non-protein coding RNA 1106

LINC01106: A Potential Drug Target for Cancer and Neurodegenerative Diseases

LINC01106 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the LINC subfamily of RNA-binding proteins, which are known for their ability to interact with RNA molecules. LINC01106 has been shown to play a role in the regulation of gene expression, and is potential drug target in the treatment of various diseases.

The LINC01106 protein is composed of 1,212 amino acids and has a calculated molecular mass of 18.1 kDa. It is expressed in a variety of tissues, including the brain, heart, and liver, and has been shown to localize to specific cellular compartments in these organisms. LINC01106 is also known to be a good candidate biomarker for certain diseases, such as cancer and neurodegenerative diseases.

One of the key functions of LINC01106 is its ability to interact with RNA molecules. This interaction allows LINC01106 to regulate the expression of other genes, and is a potential drug target in itself. LINC01106 has been shown to interact with a variety of RNA molecules, including microRNAs and large RNA molecules. These interactions are regulated by a variety of factors, including the activity of enzymes that modify the structure of LINC01106.

In addition to its role in gene regulation, LINC01106 has also been shown to play a role in the regulation of cellular processes. For example, LINC01106 has been shown to be involved in the regulation of cell adhesion, a process that is important for the maintenance of tissue structure and function. LINC01106 has also been shown to be involved in the regulation of cell signaling pathways, which are important for the regulation of cellular processes such as metabolism and growth.

Given its role in gene regulation and cellular processes, LINC01106 is a potential drug target in the treatment of various diseases. For example, LINC01106 has been shown to be involved in the regulation of cancer cell growth, and may be a useful target for cancer therapies. LINC01106 has also been shown to be involved in the regulation of neurodegenerative diseases, and may be a useful target for these therapies as well.

In conclusion, LINC01106 is a protein that has been shown to play a role in the regulation of gene expression and cellular processes. It is a potential drug target in the treatment of various diseases, including cancer and neurodegenerative diseases. Further research is needed to fully understand the role of LINC01106 in these processes, and to develop effective therapies based on this protein.

Protein Name: Long Intergenic Non-protein Coding RNA 1106

More Common Targets